Growth Metrics

Myomo (MYO) Notes Payables (2016 - 2020)

Myomo posted quarterly Notes Payables of $78045.0 for Q3 2020, down 92.17% on a QoQ basis from $996841.0 in Q2 2020.

Myomo (MYO) has 4 years of Notes Payables data on file, last reported at $78045.0 in Q3 2020.

  • For the quarter ending Q3 2020, Notes Payables changed N/A year-over-year to $78045.0; the trailing twelve-month figure through Sep 2020 stood at $78045.0 (changed N/A YoY), and the FY2019 full-year result was $1.8 million, changed N/A from the prior year.
  • Notes Payables for Q3 2020 stood at $78045.0, down from $996841.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $1.8 million in Q4 2019 and bottomed at $78045.0 in Q3 2020.
  • The 4-year median for Notes Payables is $876458.0 (2016), against an average of $859206.2.
  • Peak annual rise in Notes Payables reached 33.73% in 2017, while the deepest fall reached 33.73% in 2017.
  • A 4-year view of Notes Payables shows it stood at $876458.0 in 2016, then plunged by 33.73% to $580800.0 in 2017, then surged by 203.7% to $1.8 million in 2019, then slumped by 95.58% to $78045.0 in 2020.
  • The last three Notes Payables figures came in at $78045.0 (Q3 2020), $996841.0 (Q2 2020), and $1.8 million (Q4 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 78,045.00
Jun 30, 2020 996,841.00
Dec 31, 2019 1.76 Mn
Dec 31, 2017 580,800.00
Dec 31, 2016 876,458.00